• OPEN AN ACCOUNT
Indian Indices
Sensex
84,180.96 -780.18
( -0.92%)
Global Indices
Nasdaq
49,008.56 -474.53
(-0.96%)
Dow Jones
6,942.66 -23.16
(-0.33%)
Hang Seng
51,148.76 -813.22
(-1.57%)
Nikkei 225
10,051.56 3.35
(0.03%)
Forex
USD-INR
90.15 -0.06
(-0.07%)
EUR-INR
105.56 0.04
(0.04%)
GBP-INR
121.94 0.39
(0.32%)
JPY-INR
0.58 0.00
(0.08%)

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
530549
INE790G01031
137.4709721
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SHILPAMED
56.72
6223.41
EPS(TTM)
Face Value()
Div & Yield %
5.61
1
0.16
 

ashok leyl& ltd
Board of Sanofi India approves change in directorate
Oct 27,2025
The Board of Sanofi India at its meeting held on 27 October 2025 has approved the following-

Appointment of Deepak Arora (DIN: 07495638) as an Additional Director of the Company with effect from 27 October 2025 and as a Managing Director (Key Managerial Personnel) of the Company for a term of 3 (three) years effective from 27 October 2025.

Stepping down of Rachid Ayari as Interim Managing Director of the Company with effect from close of 26 October 2025. However, Rachid Ayari would continue to serve the Company in his role as Whole time Director and Chief Financial Officer of the Company.